Xylem Reports Second Quarter 2020 Results, Appoints Two New Board Members
Reported net income of $31 million or $0.17 per share; adjusted net income of $73 million or $0.40 per share Revenue declined 14% on a reported basis, and 12% organically, impacted by COVID-19 Strong cash performance with free cash flow of $137 million, up 117%; and operating cash flow of $181 million, up 47% RYE... Read more